Sutro Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.59 M | $13.97 M | 8.22% | 9.26% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 7.46 M | $13.73 M | 3.83% | 9.10% |
| VANGUARD GROUP INC | 02/11/2025 | 4.21 M | $7.74 M | 0.32% | 5.13% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 3.64 M | $6.70 M | 76.22% | 4.44% |
| MERCK & CO., INC. | 02/14/2025 | 2.72 M | $5.01 M | 100.00% | 3.32% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 2.57 M | $4.73 M | 100.00% | 3.13% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 2.20 M | $4.04 M | -26.69% | 2.68% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 2.20 M | $4.04 M | 0.00% | 2.68% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 2.16 M | $3.97 M | -23.73% | 2.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.00 M | $3.68 M | -11.12% | 2.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.85 M | $3.41 M | -0.16% | 2.26% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.75 M | $3.22 M | 8.82% | 2.14% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 1.73 M | $3.18 M | 0.69% | 2.11% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.71 M | $3.15 M | -1.82% | 2.09% |
| STATE STREET CORP | 02/14/2025 | 1.70 M | $3.13 M | 3.32% | 2.07% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.32 M | $2.44 M | 10.35% | 1.61% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.14 M | $2.09 M | 15.93% | 1.39% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.02 M | $1.87 M | 22.60% | 1.24% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 694,408 | $1.28 M | -62.30% | 0.85% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 547,800 | $1.01 M | -7.29% | 0.67% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 547,510 | $1.01 M | 350.96% | 0.67% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 437,079 | $804,225 | 32.62% | 0.53% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 405,618 | $746,337 | -80.04% | 0.49% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 326,317 | $600,423 | -25.34% | 0.40% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 316,292 | $581,977 | -35.68% | 0.39% |
| UBS OCONNOR LLC | 02/14/2025 | 300,621 | $553,143 | -11.12% | 0.37% |
| FMR LLC | 02/13/2025 | 277,892 | $511,321 | 47.00% | 0.34% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 271,337 | $499,260 | 0.00% | 0.33% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 251,995 | $463,671 | 0.00% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 217,627 | $400,433 | 1.20% | 0.27% |
| SHAY CAPITAL LLC | 02/14/2025 | 203,601 | $374,626 | 100.00% | 0.25% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 196,800 | $362,112 | -30.61% | 0.24% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 189,700 | $349,048 | 91.23% | 0.23% |
| UBS GROUP AG | 02/14/2025 | 183,661 | $337,936 | 10.73% | 0.22% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 180,401 | $331,938 | -1.00% | 0.22% |
| BARCLAYS PLC | 02/13/2025 | 158,814 | $293,000 | -41.83% | 0.19% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 157,683 | $290,137 | -5.94% | 0.19% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 150,758 | $277,395 | 82.68% | 0.18% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 142,186 | $261,622 | -41.92% | 0.17% |
| MAN GROUP PLC | 02/14/2025 | 132,406 | $243,627 | -19.23% | 0.16% |
| PEAK6 LLC | 02/13/2025 | 127,600 | $234,784 | 100.00% | 0.16% |
| RHUMBLINE ADVISERS | 01/30/2025 | 126,698 | $233,115 | 6.13% | 0.15% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 114,587 | $210,840 | -64.80% | 0.14% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 99,445 | $182,977 | -34.24% | 0.12% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/10/2025 | 97,096 | $178,000 | 100.00% | 0.12% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 96,370 | $177,321 | 0.00% | 0.12% |
| OMERS ADMINISTRATION CORP | 02/14/2025 | 95,150 | $175,076 | -50.00% | 0.12% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 93,033 | $171,181 | 29.08% | 0.11% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 91,797 | $168,907 | -1.54% | 0.11% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 87,810 | $161,570 | 100.00% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sutro Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 161 institutional investors and hedge funds held shares of Sutro Biopharma, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 7.59 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 7.46 M
VANGUARD GROUP INC: 4.21 M
Kynam Capital Management, LP: 3.64 M
Merck & Co., Inc.: 2.72 M
Vestal Point Capital, LP: 2.57 M
77.46% of Sutro Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 69.32 M shares in the last 24 months. This purchase volume represents approximately $141.42 M in transactions.